Improved clot formation by combined administration of activated factor VII (NovoSeven®) and fibrinogen (Haemocomplettan® P)

Anesthesia and Analgesia

Volumn 106, Issue 3, 2008, Pages 732-738

  Tanaka, Kenichi A ^a   Taketomi, Taro ^a   Szlam, Fania ^a   Calatzis, Andreas ^b   Levy, Jerrold H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRINOGEN; HEPARIN; PLASMINOGEN ACTIVATOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; FIBRINOLYSIS; HEMOSTASIS; HEPARINIZATION; HUMAN; PRIORITY JOURNAL; THROMBIN TIME; THROMBOGENESIS;

EID: 39749084002     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318163fc76     Document Type: Article

References (32)

1. RC Woodman LA Harker Bleeding complications associated with cardiopulmonary bypass Blood 76 1990 1680 1697
2. GJ Despotis JH Joist CW Hogue Jr A Alsoufiev D Joiner-Maier SA Santoro E Spitznagel JI Weitz LT Goodnough More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT Thromb Haemost 76 1996 902 908
3. ZH Meng AS Wolberg DM Monroe M Hoffman The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients J Trauma 55 2003 886 891
4. W Chandler The effects of cardiopulmonary bypass on fibrin formation and lysis: is a normal fibrinolytic response essential? J Cardiovasc Pharmacol 27 1996 S63 S68
5. M Al Douri T Shafi D Al Khudairi E Al Bokhari L Black N Akinwale MO Musa A Al Homaidhi M Al Fagih RB Andreasen Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery Blood Coagul Fibrinolysis 11 2000 S121 S127
6. HGD Hendriks J Van der Maaten J De Wolf TW Waterbolk MJH Slooff J Van der Meer An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII Anesth Analgesia 93 2001 287 289
7. KA Tanaka AA Waly WA Cooper JH Levy Treatment of excessive bleeding in Jehovah's witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven) Anesthesiology 98 2003 1513 1515
8. G Stratmann AM deSilva EE Tseng J Hambleton M Balea AJ Romo MJ Mann NL Achorn WF Moskalik CW Hoopes Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia Anesth Analg 98 2004 1635 1639
9. RM Sniecinski EP Chen JH Levy F Szlam KA Tanaka Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa Anesth Analg 104 2007 763 765
10. C Fenger-Eriksen J Ingerslev B Sorensen Coagulopathy induced by colloid plasma expanders—search for an efficacious haemostatic intervention Acta Anaesthesiol Scand 50 2006 899 900
11. D Fries A Krismer A Klingler W Streif G Klima V Wenzel T Haas P Innerhofer Effect of fibrinogen on reversal of dilutional coagulopathy. a porcine model Brit J Anaesth 95 2005 172 177
12. HC Hemker P Giesen R Al Dieri V Regnault E de Smedt R Wagenvoord T Lecompte S Beguin Calibrated automated thrombin generation measurement in clotting plasma Pathophysiol Haemost Thromb 33 2003 4 15
13. J Jesty E Beltrami Positive feedbacks of coagulation: their role in threshold regulation Arteriosclerosis Thromb Vasc Biol 25 2005 2463 2469
14. SM Slack Y Cui VT Turitto The effects of flow on blood coagulation and thrombosis Thromb Haemost 70 1993 129 134
15. M Hoffman DM Monroe A cell-based model of hemostasis Thromb Haemost 85 2001 958 965
16. CS Rinder J Bohnert HM Rinder J Mitchell K Ault R Hillman Platelet activation and aggregation during cardiopulmonary bypass Anesthesiology 75 1991 388 393
17. T Lisman J Adelmeijer S Cauwenberghs ECM Van Pampus JWM Heemskerk PG De Groot Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count J Thromb Haemost 3 2005 742 751
18. T Lisman J Adelmeijer HFG Heijnen PG de Groot Recombinant factor VIIa restores aggregation of alphaIIb/beta3-deficient platelets via tissue factor-independent fibrin generation Blood 103 2004 1720 1727
19. T Lisman FW Leebeek K Meijer J Van Der Meer HK Nieuwenhuis PG De Groot Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation Hepatology 35 2002 616 621
20. AS Wolberg GA Allen DM Monroe U Hedner HR Roberts M Hoffman High dose factor VIIa improves clot structure and stability in a model of haemophilia B Brit J Haematol 131 2005 645 655
21. LO Mosnier BN Bouma Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis Arteriosclerosis Thromb Vascul Biol 26 2006 2445 2453
22. J Felez CJ Chanquia P Fabregas EF Plow LA Miles Competition between plasminogen and tissue plasminogen activator for cellular binding sites Blood 82 1993 2433 2441
23. VG Nielsen BL Steenwyk WQ Gurley Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII J Heart Lung Transplant 25 2006 1247 1252
24. T Urano N Nagai M Matsuura H Ihara Y Takada A Takada Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity Thromb Haemost 80 1998 161 166
25. U Tebbe P Tanswell E Seifried W Feuerer KH Scholz KS Herrmann Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction Am J Cardiol 64 1989 448 453
26. NB Modi S Eppler J Breed CP Cannon E Braunwald TW Love Pharmacokinetics of a slower clearing tissue plasminogen activator variant, TNK-tPA, in patients with acute myocardial infarction Thromb Haemost 79 1998 134 139
27. PC Hebert G Wells MA Blajchman J Marshall C Martin G Pagliarello M Tweeddale I Schweitzer E Yetisir A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care New Engl J Med 340 1999 409 417
28. BD Spiess D Royston JH Levy J Fitch W Dietrich S Body J Murkin A Nadel Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes Transfusion 44 2004 1143 1148
29. H Khan J Belsher M Yilmaz B Afessa JL Winters SB Moore RD Huhmayr O Gajic Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients Chest 131 2007 1308 1314
30. GA Nuttall WC Oliver PJ Santrach S Bryant JA Dearani HV Schaff MH Ereth Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass Anesthesiology 94 2001 773 781
31. L Shore-Lesserson HE Manspeizer M DePerio S Francis F Vela-Cantos MA Ergin Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery Anesth Analg 88 1999 312 319
32. C Kawaguchi Y Takahashi Y Hanesaka A Yoshioka The in vitro analysis of the coagulation mechanism of activated factor VII using thrombelastogram Thromb Haemost 88 2002 768 772